Le Lézard
Classified in: Health, Business
Subjects: NPT, CHI, LIC, BFA

Together with EASE: IEHP Partners to Promote Awareness and Early Childhood Detection of Diabetes


RANCHO CUCAMONGA, Calif., Nov. 14, 2022 /PRNewswire/ -- In honor of National Diabetes Month, Inland Empire Health Plan (IEHP) and EASE T1D have partnered to spread awareness about Type 1 diabetes and the detection of the chronic health condition in children. Together, the two organizations will actively distribute and promote educational material and work to connect the community with supportive resources.

According to the Centers for Disease Control, the frequency of both Type 1 and Type 2 diabetes in young people is a growing clinical and public health concern. While Type 2 diabetes is preventable, Type 1 diabetes is not.

Type 1 diabetes is characterized by deficient insulin production and requires daily doses of the key hormone that converts glucose into energy. Diabetes has the potential to damage the heart, blood vessels, eyes, kidneys and nerves, according to the World Health Organization.

EASE T1D is the joint effort of two mothers, Debbie George and Michelle Thornburg, who have children with Type 1 (T1D) diabetes. Through their more than 25 years of combined experience, they have come to recognize areas of significant need and have joined forces to apply their knowledge as parents of young diabetics through Education, Awareness, Support and Empowerment (EASE).

"The goal of EASE T1D is to raise public awareness of what Type 1 diabetes is and the onset symptoms," said Debbie George, who co-founded EASE T1D. "So many times, children go undiagnosed because a parent thought it was a simple virus."

"Excessive thirst, frequent urination, weakness and weight loss are the top four symptoms," added George. "And because there are so many illnesses these symptoms could be attributed to, awareness is critical."

The non-profit group is also active in shaping state law, recently partnering with Poison lead singer and reality TV star Bret Michaels ? diagnosed with Type 1 diabetes at 6 years old ? in support of California's Senate Bill 97, which requires Type 1 diabetes information to be available on the California Department of Education's website and to be distributed to parents and guardians of K-12 students.

The bill was signed into law in October 2021 as a part of Gov. Gavin Newsom's $123.9 billion K-12 package

"Empowering parents and guardians with this information is a great step in extending preventive health care services to our community," said Dr. Wada, IEHP's chief medical officer. "This partnership will help us to fill in the gaps and truly meet our members where they are."

To learn more about EASE T1D, visit EASET1D.org.

About IEHP

With a mission to heal and inspire the human spirit, Inland Empire Health Plan (IEHP) is one of the top 10 largest Medicaid health plans and the largest not-for-profit Medicare-Medicaid plan in the country. In its 26th year, IEHP is supporting more than 1.5 million residents in Riverside and San Bernardino counties who are enrolled in Medicaid or Cal MediConnect Plans and has a growing network of over 7,800 providers and nearly 2,800 Team Members. Through dynamic partnerships with Providers and Community Organizations, paired with award-winning service and a tradition of quality care, IEHP is fully committed to their vision: We will not rest until our communities enjoy optimal care and vibrant health. For more information, visit iehp.org.

SOURCE Inland Empire Health Plan (IEHP)


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: